Gf Fund Management Co. Ltd. Biomea Fusion, Inc. Transaction History
Gf Fund Management Co. Ltd.
- $4.26 Trillion
- Q1 2025
A detailed history of Gf Fund Management Co. Ltd. transactions in Biomea Fusion, Inc. stock. As of the latest transaction made, Gf Fund Management Co. Ltd. holds 899 shares of BMEA stock, worth $1,618. This represents 0.0% of its overall portfolio holdings.
Number of Shares
899
Previous 784
14.67%
Holding current value
$1,618
Previous $3.04 Million
37.05%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding BMEA
# of Institutions
109Shares Held
16.1MCall Options Held
229KPut Options Held
354K-
Cormorant Asset Management, LP Boston, MA3.57MShares$6.43 Million0.81% of portfolio
-
Black Rock Inc. New York, NY2.34MShares$4.22 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.38MShares$2.48 Million0.0% of portfolio
-
Aisling Capital Management LP New York, NY799KShares$1.44 Million0.59% of portfolio
-
Geode Capital Management, LLC Boston, MA626KShares$1.13 Million0.0% of portfolio
About Biomea Fusion, Inc.
- Ticker BMEA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 29,290,600
- Market Cap $52.7M
- Description
- Biomea Fusion, Inc., a biopharmaceutical company, focuses on the discovery and development of covalent small molecule drugs to treat patients with genetically defined cancers and metabolic diseases. Its lead product candidate is BMF-219, an orally bioavailable, potent, and selective covalent inhibitor of menin, a transcriptional regulator in onc...